With omicron raging in the United States, it is difficult for pharmacies to maintain inventory of Covid testing at home

Read Time:5 Minute, 6 Second

Health workers distribute a free fast home Covid-19 test kit at a vaccine clinic in Philadelphia, Pennsylvania, USA on Monday, December 20, 2021.

Hannah Bell | Bloomberg | Getty Images

As cases across the state and the United States surge to record highs, George Panagiotopoulos has been working hard to maintain a stock of Covid-19 tests at a Broadway pharmacy near New York City

He said that the 200 test products received on the Saturday before Christmas were sold out “within a few hours.”

Panagiotoulos, who owns the pharmacy, has a list of 110 people waiting for him to replenish the goods on the Tuesday before Christmas. He said that the 150-piece package arrived two days late and was sold out within 48 hours. Broadway Chemists received another 150 test kits last Thursday, but most of them disappeared within a day.

As of Friday afternoon, the pharmacy had only 20 to 30 test stocks left. Panagiotopoulos predicts that as the school reopens after the holidays, parents are eager to get their children tested, and demand will remain high.

his The experience is playing out in Covid hotspots across the country, as the infection rate has reached an all-time high in the United States, which is mainly driven by the highly contagious variant of omicron.

“Demand Tsunami”

Bidding war

Abbott spokesperson John Koval (John Koval) said that Abbott’s BinaxNOW home test received emergency FDA approval in March and is currently experiencing “unprecedented demand.”

“We are sending them out as fast as possible,” he said. “This includes running our American manufacturing plants 24/7, hiring more workers and investing in automation,” he said.

Shaz Amin, the founder of a company that sells home tests online, said the surge in demand has allowed distributors to raise prices because buyers like his company WellBefore are basically caught in a bidding war. To ensure limited supply.

“No matter how much we paid for the test suite a week ago, today we will pay 25% higher,” Amin said. “Someone stood behind us and said,’I will give you 25 cents to accept WellBefore’s allocation.'”

Amin said that the shortage meant that Covid test kits were sold out even before they arrived.


Ryen Neuman, vice president of logistics at Sunline Supply and Arnold’s Office Furniture, said that they usually pay a 10% deposit for orders for health and safety products, and then rest when they arrive.

But for the Covid test suite, they “must pay 100% of the product cost before seeing, viewing, and smelling it” because the demand for testing is so high, he said, noting that he thinks the market for test suites will be “tightened.” At least six months.

“It seems that the output cannot meet the current needs of the American population,” he said.

Several wholesale buyers stated that they are trying to stock some of the lesser-known brands that have been approved for sale by the Food and Drug Administration. They work in a similar way to the Covid test of well-known brands such as Abbott’s BinaxNOW and Quidel’s QuickVue. For example, Neumann said that some of the more popular test distributors charge too much, which makes less well-known brands more attractive.

Shortage of raw materials

Matt Regan, president and chief executive officer of Code 1 Supply, a medical supplies distributor, said on Thursday that the test kit components have dried up in the past 7 to 10 days. Reagan said that his business partners told him that there was a shortage of raw materials for the test kits. He said they also told him that distributors are prioritizing orders from federal agencies over other buyers.

Three other companies that sell Covid at-home testing, including iPromo, Sunline Supply, and the non-profit project N95, that CNBC talked to, also stated that they were also told that the Biden government’s new plan to provide 500 million home testing to the public is delaying them Own plan. Shipments. But the White House said its plan should not hinder existing agreements between private parties.

A White House official said in a statement to CNBC: “Because we have this extra capacity, we can make this purchase without interrupting the existing manufacturers’ commitments to states or organizations.”

However, Steven Tang, CEO of OraSure Technologies, a rapid test manufacturer, said that rapid increase in test manufacturing is difficult. He said that several test components are in short supply, and when demand fluctuates so greatly, it is a challenge to staff to add more shifts to conduct more tests.

“As early as May and June, when we thought that vaccines would solve all problems, people started to reduce supply, reduce labor and shifts,” Tang said. He said that in the fall, the demand for testing began to rise again. “When demand is consistent and predictable, companies, especially those that are expanding, will flourish. We are not in a consistent and predictable situation now,” he said.

Ramp production

To be sure, test kit manufacturers are increasing production, and the new company is waiting for FDA approval to begin selling their tests to the public. Therefore, some wholesalers hope that it will be easier to obtain Covid testing in the coming months.

WellBefore’s Amin said that if the FDA approves more tests in the next few weeks, the United States will be in a “better position” by the second quarter, if not earlier.

Anne Miller, executive director of the non-profit project N95, believes that by the middle of this month, the test tightening will begin to ease.

At the same time, Abbott, one of the largest test manufacturers in the United States, is increasing supply. Spokesperson Kowal said that its goal is to conduct 70 million BinaxNOW rapid tests in January, up from 50 million in December, adding that the company can “further scale up in the next few months.”

-Sevanny Campos of CNBC contributed to this report.

Subscribe to CNBC on YouTube.

Watch: The Biden government will distribute 500 million free home Covid tests

If you want to know more about business please go to https://updatednews24.com/category/business/

0 %
0 %
0 %
0 %
0 %
0 %
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. View more
Cookies settings
Privacy & Cookie policy
Privacy & Cookies policy
Cookie name Active

Who we are

Suggested text: Our website address is: https://updatednews24.com.


Suggested text: When visitors leave comments on the site we collect the data shown in the comments form, and also the visitor’s IP address and browser user agent string to help spam detection. An anonymized string created from your email address (also called a hash) may be provided to the Gravatar service to see if you are using it. The Gravatar service privacy policy is available here: https://automattic.com/privacy/. After approval of your comment, your profile picture is visible to the public in the context of your comment.


Suggested text: If you upload images to the website, you should avoid uploading images with embedded location data (EXIF GPS) included. Visitors to the website can download and extract any location data from images on the website.


Suggested text: If you leave a comment on our site you may opt-in to saving your name, email address and website in cookies. These are for your convenience so that you do not have to fill in your details again when you leave another comment. These cookies will last for one year. If you visit our login page, we will set a temporary cookie to determine if your browser accepts cookies. This cookie contains no personal data and is discarded when you close your browser. When you log in, we will also set up several cookies to save your login information and your screen display choices. Login cookies last for two days, and screen options cookies last for a year. If you select "Remember Me", your login will persist for two weeks. If you log out of your account, the login cookies will be removed. If you edit or publish an article, an additional cookie will be saved in your browser. This cookie includes no personal data and simply indicates the post ID of the article you just edited. It expires after 1 day.

Embedded content from other websites

Suggested text: Articles on this site may include embedded content (e.g. videos, images, articles, etc.). Embedded content from other websites behaves in the exact same way as if the visitor has visited the other website. These websites may collect data about you, use cookies, embed additional third-party tracking, and monitor your interaction with that embedded content, including tracking your interaction with the embedded content if you have an account and are logged in to that website.

Who we share your data with

Suggested text: If you request a password reset, your IP address will be included in the reset email.

How long we retain your data

Suggested text: If you leave a comment, the comment and its metadata are retained indefinitely. This is so we can recognize and approve any follow-up comments automatically instead of holding them in a moderation queue. For users that register on our website (if any), we also store the personal information they provide in their user profile. All users can see, edit, or delete their personal information at any time (except they cannot change their username). Website administrators can also see and edit that information.

What rights you have over your data

Suggested text: If you have an account on this site, or have left comments, you can request to receive an exported file of the personal data we hold about you, including any data you have provided to us. You can also request that we erase any personal data we hold about you. This does not include any data we are obliged to keep for administrative, legal, or security purposes.

Where we send your data

Suggested text: Visitor comments may be checked through an automated spam detection service.
Save settings
Cookies settings